跳至主要内容
临床试验/IRCT20180802040678N4
IRCT20180802040678N4招募中3 期

Evaluation of the effects of Losartan in patients with corona virus disease 2019

Tabriz University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Laboratory (RT-PCR of oropharyngeal swab) confirmed COVID-19
  • Stable hemodynamic condition
  • Blood pressure =130/85 mmHg

排除标准

  • Patient's critical condition
  • Cough exacerbation after initiating Losartan
  • Increasing blood potassium levels or high baseline potassium levels
  • Shock or decreasing blood pressure = 90/60 mmHg after Losartan initiating
  • Acute hepatic failure
  • Acute renal failure
  • Bilateral renal artery stenosis
  • History of uncontrolled hypertension
  • Pregnancy and lactation
  • History of treatment with ACE inhibitors and ARB inhibitors
  • Treatment with phenobarbital, rifampin and fluconazole

研究者

相似试验

Evaluation of the effects of Losartan in patients... | 临床试验